Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
98.47m
Last Price
$3.06
52-Week Range
$2.145 - $5.13
10/09/2024 08:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808